Disorders of sex differentiation: state of the problem 15 years after the Chicago consensus
https://doi.org/10.14341/probl12514
Abstract
It is well known that the nomenclature and classification were changed in 2005 at the international consensus conference on intersex disorders, held in Chicago, where, among others, the following recommendations were proposed: (1) all children should be assigned a gender identity, and this should be done as quickly as possible, taking into account the time required for the examination. (2) all infants with congenital adrenal hyperplasia and 46,XX karyotype, including those with pronounced masculinization, must be raised as women. (3) Surgical treatment should be performed early and in cases of feminizing genitoplasty, clitoral reduction should be performed simultaneously with reconstruction of the urogenital sinus (separation of the vagina and urethra). An analysis of contemporary literature shows that all these theories, proposed 15 years ago at the Chicago meeting, failed to stand the test of time. New nomenclature and classification are constantly being revised. Currently, many groups of patients want to abolish the term «sexual maturity disorders.» Recommendations regarding gender reassignment and appropriate early surgical treatment have been completely ignored in some countries. All this was largely facilitated by the confrontational activities of a number of support groups.
About the Authors
Nikolay D. Shiryaev
Northern State Medical University
Russian Federation
Russian Federation
MD, PhD, Professor
Ilya M. Kagantsov
Pitirim Sorokin Syktyvkar State University; Republican Children’s Clinical Hospital
Russian Federation
Russian Federation
MD, PhD
Vladimir V. Sizonov
Rostov Regional Pediatric Hospital; RostSMU of Minzdrav of Russia
Russian Federation
Russian Federation
MD, PhD
References
1. Lee PA, Houk CP, Ahmed SF, et al. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118(2):e488−e500. doi: 10.1542/peds.2006-0738.
2. Houk CP, Hughes IA, Ahmed SF, et al. Summary of consensus statement on intersex disorders and their management. International Intersex Consensus Conference. Pediatrics. 2006;118(2):753−757. doi: 10.1542/peds.2006-0737.
3. Hughes IA. The quiet revolution: disorders of sex development. Best Pract Res Clin Endocrinol Metab. 2010;24(2):159−162. doi: 10.1016/j.beem.2010.03.005.
4. Hughes IA, Nihoul-Fekete C, Thomas B, Cohen-Kettenis PN. Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab. 2007;21(3):351−365. doi: 10.1016/j.beem.2007.06.003.
5. González R, Ludwikowski B. Should CAH in females be classified as DSD? Front Pediatr. 2016;4:48. doi: 10.3389/fped.2016.00048.
6. Barthold JS. Disorders of sex differentiation: a pediatric urologist’s perspective of new terminology and recommendations. J Urol. 2011;185(2):393−400. doi: 10.1016/j.juro.2010.09.083.
7. Lin-Su K, Lekarev O, Poppas DP, Vogiatzi MG. Congenital adrenal hyperplasia patient perception of disorders of sex development’ nomenclature. Int J Pediatr Endocrinol. 2015;2015(1):9. doi: 10.1186/s13633-015-0004-4.
8. Johnson EK, Rosoklija I, Finlayson C, et al. Attitudes towards «disorders of sex development» nomenclature among affected individuals. J Pediatr Urol. 2017;13(6):608.e1−608.e8. doi: 10.1016/j.jpurol.2017.03.035.
9. Tiryaki S, Tekin A, Yağmur İ, et al. Parental perception of terminology of disorders of sex development in western Turkey. J Clin Res Pediatr Endocrinol. 2018;10(3):216−222. doi: 10.4274/jcrpe.0007.
10. Lee PA, Nordenström A, Houk CP, et al. Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr. 2016;85(3):158–180. doi: 10.1159/000442975.
11. Wang LC, Poppas DP. Surgical outcomes and complications of reconstructive surgery in the female congenital adrenal hyperplasia patient: what every endocrinologist should know. J Steroid Biochem Molec Biol. 2017;165(Pt A):137−144. doi: 10.1016/j.jsbmb.2016.03.021.
12. Canning DA. Re: Attitudes towards «disorders of sex development» nomenclature among affected individuals. J Urol. 2018;200(4):685−686. doi: 10.1016/j.juro.2018.07.006.
13. Davies JH, Knight EJ, Savage A, et al. Evaluation of terminology used to describe disorders of sex development. J Pediatr Urol. 2011;7(4):412−415. doi: 10.1016/j.jpurol.2010.07.004.
14. Mouriquand PJ. Commentary to «Attitudes towards ‘disorders of sex development’ nomenclature among affected». J Pediatr Urol. 2017;13(6):609. doi: 10.1016/j.jpurol.2017.03.041.
15. Aaronson IA, Aaronson AJ. How should we classify intersex disorders? J Pediat Urol. 2010;6(5):443−446. doi: 10.1016/j.jpurol.2010.04.008.
16. Wu HY, Snyder HM III. Intersex. In Docimo SG, Canning DA, Knoury AE, eds. Clinical pediatric urology. Ch. 68. 5th ed. London, Informa healthcare; 2007. Р. 1147−1160. doi: 10.1201/b13795-75.
17. Mouriquand P, Gorduza DB, Gay CL, et al. Surgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how? J Pediatr Urol. 2016;12(3):139−149. doi: 10.1016/j.jpurol.2016.04.001.
18. Hughes IA. How should we classify intersex disorders? J Pediatr Urol. 2010;6(5):447−448. doi: 10.1016/j.jpurol.2010.04.005.
19. Grinspon RP, Rey RA. When hormone defects cannot explain it: malformative disorders of sex development. Birth Defects Res C Embryo Today. 2014:102(4):359−373. doi: 10.1002/bdrc.21086.
20. Lee P, Houk C, Husmann D. Should male gender assignment be considered in the markedly virilized patient with 46,XX and congenital adrenal hyperplasia? J Urol. 2010;184(4 Suppl):1786−1792. doi: 10.1016/j.juro.2010.03.116.
21. Houk CP, Lee PA. Approach to assigning gender in 46,XX congenital adrenal hyperplasia with male external genitalia: replacing dogmatism with pragmatism. J Clin Endocrinol Metab. 2010;95(10):4501−4508. doi: 10.1210/jc.2010-0714.
22. Lee PA, Houk CP. Review of outcome information in 46,XX patients with congenital adrenal hyperplasia assigned/reared male: What does it say about gender assignment? Int J Pediatr Endocrinol. 2010;2010:982025. doi: 10.1155/2010/982025.
23. Lee PA, Houk CP. Key discussions from the Working Party on Disorders of Sex Development (DSD) evaluation, Foundation Merieux, Annecy, France, March 14-17, 2012. Int J Pediatr Endocrinol. 2013;2013(1):12. doi: 10.1186/1687-9856-2013-12.
24. Ширяев Н.Д., Каганцов И.М., Сизонов В.В., Дубров В.И. Нарушение половой дифференцировки у детей: критический взгляд на нерешенные вопросы (часть I и II) // Урология. — 2018. — №3. — С. 116−125. [Shiryaev ND, Kagantsov IM, Sizonov VV, Dubrov VI. Disorders of sexual differentiation in children: a critical look at open questions (part I and II). Urology. 2018;(3):116−125. (In Russ.)].doi: 10.18565/urology.2018.2.121-125.
25. Raveenthiran V. Neonatal sex assignment in disorders of sex development: A philosophical introspection. J Neonat Surg. 2017;6(3):58. doi: 10.21699/jns.v6i3.604.
26. Sharma S, Gupta DK. Male genitoplasty for 46,XX congenital adrenal hyperplasia patients presenting late and reared as males. Indian J Endocrinol Metab. 2012;16(6):935−938. doi: 10.4103/2230-8210.102994.
27. Goyal A, Boro H, Khadgawat R. Male gender identity and reversible hypokalemic hypertension in a 46,XX child with 11-beta-hydroxylase deficiency congenital adrenal hyperplasia. Cureus. 2019;11(7):e5248. doi: 10.7759/cureus.5248.
28. Khattab A, Yau M, Qamar A, et al. Long term outcomes in 46,XX adult patients with congenital adrenal hyperplasia reared as males. J Steroid Biochem Mol Biol. 2017;165(Pt A):12−17. doi: 10.1016/j.jsbmb.2016.03.033.
29. Apóstolos R, Canguçu-Campinho AK, Lago R, et al. Gender identity and sexual function in 46,XX patients with congenital adrenal hyperplasia raised as males. Arch Sex Behav. 2018;47(8):2491−2496. doi: 10.1007/s10508-018-1299-z.
30. Kim HJ. Response to Apóstolos et al.’s (2018) «Gender identity and sexual function in 46,XX patients with congenital adrenal hyperplasia raised as males». Arch Sex Behav. 2019;48(3):675−677. doi: 10.1007/s10508-018-1386-1.
31. Pearce M, DeMartino L, McMahon R, et al. Newborn screening for congenital adrenal hyperplasia in New York State. Mol Genet Metab Rep. 2016;7:1−7. doi: 10.1016/j.ymgmr.2016.02.005.
32. Witchel SF. Newborn screening for congenital adrenal hyperplasia: beyond 17-hydroxyprogesterone concentrations. J Pediatr (Rio J). 2019;95(3):257−259. doi: 10.1016/j.jped.2018.06.003.
33. Saraf AJ, Nahata L. Fertility counseling and preservation: considerations for the pediatric endocrinologist. Transl Pediatr. 2017;6(4):313−322. doi: 10.21037/tp.2017.07.02.
34. Chatziaggelou A, Sakkas EG, Votino R, et al. Assisted reproduction in congenital adrenal hyperplasia. Front Endocrinol (Lausanne). 2019;10:723. doi: 10.3389/fendo.2019.00723.
35. Almasri J, Zaiem F, Rodriguez-Gutierrez R, et al. Genital reconstructive surgery in females with congenital adrenal hyperplasia: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2018;103(11):4089−4096. doi: 10.1210/jc.2018-01863.
36. De Jesus LE, Costa EC, Dekermacher S. Gender dysphoria and XX congenital adrenal hyperplasia: how frequent is it? Is male-sex rearing a good idea? J Pediatr Surg. 2019;54(11):2421−2427. doi: 10.1016/j.jpedsurg.2019.01.062.
37. Daae E, Feragen KB, Waehre A, et al. Sexual orientation in individuals with congenital adrenal hyperplasia: a systematic review. Front Behav Neurosci. 2020;14:38. doi: 10.3389/fnbeh.2020.00038.
38. Krege S, Eckoldt F, Richter-Unruh A, et al. Variations of sex development: The first German interdisciplinary consensus paper. J Pediatr Urol. 2019;15(2):114−123. doi: 10.1016/j.jpurol.2018.10.008.
39. Council of Europe, Parliamentary Assembly (PACE). Resolution 2191. Promoting the human rights of and eliminating discrimination against intersex people [cited 2017 October 12]. Available from: https://assembly.coe.int/nw/xml/XRef/Xref-DocDetails-en.asp?FileID=24232&lang=en.
40. Ширяев Н.Д., Каганцов И.М. Очерки реконструктивной хирургии наружных половых органов у детей. Часть II: Изолированные искривление и торсия полового члена, эписпадия, нарушения полового развития. — Сыктывкар, 2012. — 96 с. [Shiryaev ND, Kagantsov IM. Sketches of reconstructive surgery of external genitaliy in children. Part II: isolated curvature and torsion of the penis, epispadia, disorders of sex development. Syktyvkar; 2012. 96 p. (In Russ.)].
41. Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133−4160. doi: 10.1210/jc.2009-2631.
42. Speiser PW, Arlt W, Auchus RJ, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(11):4043−4088. doi: 10.1210/jc.2018-01865.
43. Mouriquand P, Caldamone A, Malone P, et al. The ESPU/SPU standpoint on the surgical management of disorders of sex development (DSD). J Pediatr Urol. 2014;10(1):8−10. doi: 10.1016/j.jpurol.2013.10.023.
44. Nokoff NJ, Palmer B, Mullins AJ, et al. Prospective assessment of cosmesis before and after genital surgery. J Pediatr Urol. 2017;13(1):28.e1–28.e6. doi: 10.1016/j.jpurol.2016.08.017.
45. Bernabé KJ, Nokoff NJ, Galan D, et al. Preliminary report: surgical outcomes following genitoplasty in children with moderate to severe genital atypia. J Pediatr Urol. 2018;14(2):157.e1−157.e8. doi: 10.1016/j.jpurol.2017.11.019.
46. Jesus LE. Feminizing genitoplasties: where are we now? J Pediatr Urol. 2018;14(5):407−415. doi: 10.1016/j.jpurol.2018.03.020.
47. Ludwikowski B, González R. The surgical correction of urogenital sinus in patients with DSD: 15years after description of total urogenital mobilization (TUM) in children. Front Pediatr. 2013;1:41. doi: 10.3389/fped.2013.00041.
48. Bailez MM, Cuenca ES, Dibenedetto V. Urinary continence following repair of intermediate and high urogenital sinus (UGS) in CAH. Experience with 55 cases. Front Pediatr. 2015;2:67. doi: 10.3389/fped.2014.00067.
49. Stites J, Bernabe KJ, Galan D, et al. Urinary continence outcomes following vaginoplasty in patients with congenital adrenal hyperplasia. J Pediatr Urol. 2017;13(1):38e1–38.e7. doi: 10.1016/j.jpurol.2016.10.012.
50. Jesus VM, Buriti F, Lessa R, et al. Total urogenital sinus mobilization for ambiguous genitalia. J Pediatr Surg. 2018;53(4):808−812. doi: 10.1016/j.jpedsurg.2017.08.014.
51. Hemesath TP, Pedroso de Paula LC, Carvalho CG, et al. Controversies on timing of sex assignment and surgery in individuals with disorders of sex development: A perspective. Front Pediatr. 2019;6:419. doi: 10.3389/fped.2018.00419.
52. Binet A, Lardy H, Geslin D, et al. Should we question early feminizing genitoplasty for patients with congenital adrenal hyperplasia and XX karyotype? J Pediatr Surg. 2016;51(3):465−468. doi: 10.1016/j.jpedsurg.2015.10.004.
53. Szymanski KM, Whittam B, Kaefer M, et al. Parental decisional regret and views about optimal timing of female genital restoration surgery in congenital adrenal hyperplasia. J Pediatr Urol. 2018;14(2):156.e1−156.e7. doi: 10.1016/j.jpurol.2017.11.012.
54. Wolffenbuttel KP, Hoebeke P. Open letter to the council of Europe. J Pediatr Urol. 2018;14(1):4−5. doi: 10.1016/j.jpurol.2018.02.004.
55. https://www.espu.org/ [Internet]. ESPU-SPU Consensus statement 2020. Management of differences of sex development (DSD). Available from: https://www.espu.org/members/documents/383-espu-spu-consensus-statement-2020-management-of-differences-of-sex-development-dsd.
56. Gardner M, Sandberg DE. Navigating surgical decision making in disorders of sex development (DSD). Front Pediatr. 2018;6:339. doi: 10.3389/fped.2018.00339.
57. Viau-Colindres J, Axelrad M, Karaviti L. Bringing back the term ’intersex’. Pediatrics. 2017;140(5):e20170505. doi: 10.1542/peds.2017-0505.
58. United Nations General Assembly. Méndez JE. Report of the Special rapporteur on torture and other cruel, inhuman or degrading treatment or punishment [cites 2013 February 1]. Available from: http://www.ohchr.org/Documents/HRBodies/HRCouncil/RegularSession/Session22/A.HRC.22.53_English.pdf.
59. I Want to Be Like Nature Made Me. Medically Unnecessary Surgeries on Intersex Children in the US [Internet]. Human Rights Watch; 2017. Available from: https://www.hrw.org/sites/default/files/report_pdf/lgbtintersex0717_web_0.pdf.
60. Amnesty International [Internet]. Europe: first, do no harm: ensuring the rights of children with variations of sex characteristics in Denmark and Germany [cites 2017 May 9]. Available from: https://www.amnesty.org/en/documents/eur01/6086/2017/en/.
61. Lee PA, Houk CP. The role of support groups, advocacy groups, and other interested parties in improving the care of patients with congenital adrenal hyperplasia: pleas and warnings. Int J Pediatr Endocrinol. 2010;2010:563640. doi: 10.1155/2010/563640.
62. Lossie AC, Green J. Building trust: the history and ongoing relationships amongst DSD clinicians, researchers, and patient advocacy groups. Hormone Metab Res. 2015;47(5):344−350. doi: 10.1055/s-0035-1548793.
63. Wolffenbuttel KP. A holistic approach in children with DSD. J Pediatr Urol. 2019;15(2):124−125. doi: 10.1016/j.jpurol.2019.02.022.
64. Diamond DA. Commentary to variations of sex development: first German interdisciplinary consensus paper. J Pediatr Urol. 2019;15(2):126−127. doi: 10.1016/j.jpurol.2019.03.012.
65. Zeeman L, Sherriff N, Browne K, et al. A review of lesbian, gay, bisexual, trans and intersex (LGBTI) health and healthcare inequalities. Eur J Public Health. 2019;29(5):974–980. doi: 10.1093/eurpub/cky226.
66. Meyer-Bahlburg HF. Misrepresentation of evidence favoring early normalizing surgery for atypical sex anatomies: Response to Baratz and Feder (2015). Arch Sex Behav. 2015;44(7):1765−1768. doi: 10.1007/s10508-015-0602-5.
67. Rolston AM, Gardner M, van Leeuwen K, et al. Disorders of sex development (DSD): Clinical service delivery in the United States. Am J Med Genet C Semin Med Genet. 2017;175(2):268−278. doi: 10.1002/ajmg.c.31558.
68. Nihoul-Fekete C. Surgical management of the intersex patient: An overview in 2003. J Pediatr Surg. 2004;39(2):144−145. doi: 10.1016/j.jpedsurg.2003.12.039.
69. Creighton S. Surgery for intersex. J R Soc Med. 2001;94(5):218−220. doi: 10.1177/014107680109400505.
70. Liao LM, Hegarty P, Creighton S, et al. Clitoral surgery on minors: an interview study with clinical experts of differences of sex development. BMJ Open. 2019;9:e025821. doi: 10.1136/bmjopen-2018-0258271.
71. Telles-Silveira M, Knobloch F, Kater CE. Management framework paradigms for disorders of sex development. Arch Endocrinol Metab. 2015;59(5):383−390. doi: 10.1590/2359-3997000000084.
72. Diamond DA, Swartz J, Tishelman A, et al. Management of pediatric patients with DSD and ambiguous genitalia: Balancing the child’s moral claims to self-determination with parental values and preferences. J Pediatr Urol. 2018;14(5):416.e1−416.e5. doi: 10.1016/j.jpurol.2018.04.029.
Supplementary files
Review
For citations:
Shiryaev N.D., Kagantsov I.M., Sizonov V.V. Disorders of sex differentiation: state of the problem 15 years after the Chicago consensus. Problems of Endocrinology. 2020;66(3):70-80. (In Russ.) https://doi.org/10.14341/probl12514
Views:
4419
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
